Different animal models reveal that inflammasome deficiency-associated changes in the gut microbiota composition were associated with exacerbated hepatic steatosis and inflammation through the influx of TLR4 and TLR9 agonists into the portal circulation. Here, TLR9 is linked to Hepatic steatosis.